Perigon Wealth Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Perigon Wealth Management’s Portfolio FDMT Stock Details FDMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.09M	Hold	146,185	–	–	0.03%	398
2026 Q2	$1.94M	Sell	146,185 -12	-0%	-$117	0.03%	419
2026 Q1	$1.36M	Buy	146,197 +64	+0%	+$557	0.02%	451
2025 Q4	$1.1M	Hold	146,133	–	–	0.02%	512
2025 Q3	$1.27M	Hold	146,133	–	–	0.03%	448
2025 Q2	$542K	Hold	146,133	–	–	0.01%	646
2025 Q1	$472K	Hold	146,133	–	–	0.01%	655
2024 Q4	$684K	Sell	146,133 -37	-0%	-$290	0.02%	550
2024 Q3	$1.58M	Hold	146,170	–	–	0.04%	326
2024 Q2	$3.07M	Buy	146,170 +20	+0%	+$502	0.09%	199
2024 Q1	$4.66M	Sell	146,150 -100,000	-41%	-$2.55M	0.14%	151
2023 Q4	$4.99M	Hold	246,150	–	–	0.16%	130
2023 Q3	$3.13M	Buy	246,150 +75	+0%	+$1.25K	0.13%	157
2023 Q2	$4.45M	Hold	246,075	–	–	0.17%	126
2023 Q1	$4.23M	Hold	246,075	–	–	0.24%	94
2022 Q4	$5.47M	Sell	246,075 -4,400	-2%	-$68K	0.34%	72
2022 Q3	$2.01M	Sell	250,475 -98,271	-28%	-$890K	0.17%	121
2022 Q2	$2.43M	Sell	348,746 -208,729	-37%	-$2.03M	0.2%	104
2022 Q1	$8.43M	Sell	557,475 -209,492	-27%	-$3.29M	0.6%	30
2021 Q4	$16.8M	Buy	+766,967	New	+$18.8M	1.2%	13

Other funds holding FDMT

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

Pacific Center for Financial Services San Ramon, California $477M AUM 12.74% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Perigon Wealth Management's FDMT Position: Q3 2026 in Review

Perigon Wealth Management held its 4D Molecular Therapeutics (FDMT) position steady in Q3 2026 at 146,185 shares worth $2.09M. The position accounts for 0.03% of the portfolio, ranked #398.

Perigon Wealth Management first reported a position in FDMT in Q4 2021 and has held it in 20 quarters since. The position peaked at $16.8M in Q4 2021. 17 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.

Perigon Wealth Management held 146,185 shares of 4D Molecular Therapeutics worth $2.09M as of Q3 2026.
Perigon Wealth Management left its 4D Molecular Therapeutics share count unchanged in Q3 2026.
4D Molecular Therapeutics made up 0.03% of Perigon Wealth Management's portfolio in Q3 2026, its #398 holding.
Perigon Wealth Management first reported a position in 4D Molecular Therapeutics in Q4 2021 and has held it in 20 quarters since.
Perigon Wealth Management's 4D Molecular Therapeutics position peaked at $16.8M in Q4 2021.
17 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.

Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.